Global Prostate Cancer Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prostate Cancer Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Prostate Cancer Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Prostate Cancer Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Prostate Cancer Vaccines Segment by Type

2.2.1 Tablet

2.2.2 Injection

2.3 Prostate Cancer Vaccines Sales by Type

2.3.1 Global Prostate Cancer Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Prostate Cancer Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Prostate Cancer Vaccines Sale Price by Type (2017-2022)

2.4 Prostate Cancer Vaccines Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Prostate Cancer Vaccines Sales by Application

2.5.1 Global Prostate Cancer Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Prostate Cancer Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Prostate Cancer Vaccines Sale Price by Application (2017-2022)

3 Global Prostate Cancer Vaccines by Company

3.1 Global Prostate Cancer Vaccines Breakdown Data by Company

3.1.1 Global Prostate Cancer Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Prostate Cancer Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Prostate Cancer Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Prostate Cancer Vaccines Revenue by Company (2020-2022)

3.2.2 Global Prostate Cancer Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Prostate Cancer Vaccines Sale Price by Company

3.4 Key Manufacturers Prostate Cancer Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prostate Cancer Vaccines Product Location Distribution

3.4.2 Players Prostate Cancer Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prostate Cancer Vaccines by Geographic Region

4.1 World Historic Prostate Cancer Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Prostate Cancer Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Prostate Cancer Vaccines Annual Revenue by Geographic Region

4.2 World Historic Prostate Cancer Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Prostate Cancer Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Prostate Cancer Vaccines Annual Revenue by Country/Region

4.3 Americas Prostate Cancer Vaccines Sales Growth

4.4 APAC Prostate Cancer Vaccines Sales Growth

4.5 Europe Prostate Cancer Vaccines Sales Growth

4.6 Middle East & Africa Prostate Cancer Vaccines Sales Growth

5 Americas

5.1 Americas Prostate Cancer Vaccines Sales by Country

5.1.1 Americas Prostate Cancer Vaccines Sales by Country (2017-2022)

5.1.2 Americas Prostate Cancer Vaccines Revenue by Country (2017-2022)

5.2 Americas Prostate Cancer Vaccines Sales by Type

5.3 Americas Prostate Cancer Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prostate Cancer Vaccines Sales by Region

6.1.1 APAC Prostate Cancer Vaccines Sales by Region (2017-2022)

6.1.2 APAC Prostate Cancer Vaccines Revenue by Region (2017-2022)

6.2 APAC Prostate Cancer Vaccines Sales by Type

6.3 APAC Prostate Cancer Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Prostate Cancer Vaccines by Country

7.1.1 Europe Prostate Cancer Vaccines Sales by Country (2017-2022)

7.1.2 Europe Prostate Cancer Vaccines Revenue by Country (2017-2022)

7.2 Europe Prostate Cancer Vaccines Sales by Type

7.3 Europe Prostate Cancer Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prostate Cancer Vaccines by Country

8.1.1 Middle East & Africa Prostate Cancer Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Prostate Cancer Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Prostate Cancer Vaccines Sales by Type

8.3 Middle East & Africa Prostate Cancer Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Prostate Cancer Vaccines

10.3 Manufacturing Process Analysis of Prostate Cancer Vaccines

10.4 Industry Chain Structure of Prostate Cancer Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Prostate Cancer Vaccines Distributors

11.3 Prostate Cancer Vaccines Customer

12 World Forecast Review for Prostate Cancer Vaccines by Geographic Region

12.1 Global Prostate Cancer Vaccines Market Size Forecast by Region

12.1.1 Global Prostate Cancer Vaccines Forecast by Region (2023-2028)

12.1.2 Global Prostate Cancer Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Prostate Cancer Vaccines Forecast by Type

12.7 Global Prostate Cancer Vaccines Forecast by Application

13 Key Players Analysis

13.1 Dendreon Corporation

13.1.1 Dendreon Corporation Company Information

13.1.2 Dendreon Corporation Prostate Cancer Vaccines Product Offered

13.1.3 Dendreon Corporation Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Dendreon Corporation Main Business Overview

13.1.5 Dendreon Corporation Latest Developments

13.2 Bavarian Nordic

13.2.1 Bavarian Nordic Company Information

13.2.2 Bavarian Nordic Prostate Cancer Vaccines Product Offered

13.2.3 Bavarian Nordic Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bavarian Nordic Main Business Overview

13.2.5 Bavarian Nordic Latest Developments

13.3 Advantagene

13.3.1 Advantagene Company Information

13.3.2 Advantagene Prostate Cancer Vaccines Product Offered

13.3.3 Advantagene Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Advantagene Main Business Overview

13.3.5 Advantagene Latest Developments

13.4 OncBioMune Pharmaceuticals

13.4.1 OncBioMune Pharmaceuticals Company Information

13.4.2 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product Offered

13.4.3 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 OncBioMune Pharmaceuticals Main Business Overview

13.4.5 OncBioMune Pharmaceuticals Latest Developments

13.5 Advaxis immunotherapies

13.5.1 Advaxis immunotherapies Company Information

13.5.2 Advaxis immunotherapies Prostate Cancer Vaccines Product Offered

13.5.3 Advaxis immunotherapies Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Advaxis immunotherapies Main Business Overview

13.5.5 Advaxis immunotherapies Latest Developments

13.6 SOTIO

13.6.1 SOTIO Company Information

13.6.2 SOTIO Prostate Cancer Vaccines Product Offered

13.6.3 SOTIO Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 SOTIO Main Business Overview

13.6.5 SOTIO Latest Developments

13.7 Cleveland BioLabs Inc.

13.7.1 Cleveland BioLabs Inc. Company Information

13.7.2 Cleveland BioLabs Inc. Prostate Cancer Vaccines Product Offered

13.7.3 Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Cleveland BioLabs Inc. Main Business Overview

13.7.5 Cleveland BioLabs Inc. Latest Developments

13.8 Curevac AG

13.8.1 Curevac AG Company Information

13.8.2 Curevac AG Prostate Cancer Vaccines Product Offered

13.8.3 Curevac AG Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Curevac AG Main Business Overview

13.8.5 Curevac AG Latest Developments

13.9 Mediolanum Farmaceutici

13.9.1 Mediolanum Farmaceutici Company Information

13.9.2 Mediolanum Farmaceutici Prostate Cancer Vaccines Product Offered

13.9.3 Mediolanum Farmaceutici Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Mediolanum Farmaceutici Main Business Overview

13.9.5 Mediolanum Farmaceutici Latest Developments

13.10 Pfizer Inc.

13.10.1 Pfizer Inc. Company Information

13.10.2 Pfizer Inc. Prostate Cancer Vaccines Product Offered

13.10.3 Pfizer Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Pfizer Inc. Main Business Overview

13.10.5 Pfizer Inc. Latest Developments

13.11 Vaccitech

13.11.1 Vaccitech Company Information

13.11.2 Vaccitech Prostate Cancer Vaccines Product Offered

13.11.3 Vaccitech Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Vaccitech Main Business Overview

13.11.5 Vaccitech Latest Developments

13.12 Sensei Biotherapeutics

13.12.1 Sensei Biotherapeutics Company Information

13.12.2 Sensei Biotherapeutics Prostate Cancer Vaccines Product Offered

13.12.3 Sensei Biotherapeutics Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Sensei Biotherapeutics Main Business Overview

13.12.5 Sensei Biotherapeutics Latest Developments

13.13 Medigene AG

13.13.1 Medigene AG Company Information

13.13.2 Medigene AG Prostate Cancer Vaccines Product Offered

13.13.3 Medigene AG Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Medigene AG Main Business Overview

13.13.5 Medigene AG Latest Developments

13.14 Ultimovacs

13.14.1 Ultimovacs Company Information

13.14.2 Ultimovacs Prostate Cancer Vaccines Product Offered

13.14.3 Ultimovacs Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Ultimovacs Main Business Overview

13.14.5 Ultimovacs Latest Developments

13.15 Oncovir Inc.

13.15.1 Oncovir Inc. Company Information

13.15.2 Oncovir Inc. Prostate Cancer Vaccines Product Offered

13.15.3 Oncovir Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Oncovir Inc. Main Business Overview

13.15.5 Oncovir Inc. Latest Developments

13.16 UbiVac

13.16.1 UbiVac Company Information

13.16.2 UbiVac Prostate Cancer Vaccines Product Offered

13.16.3 UbiVac Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 UbiVac Main Business Overview

13.16.5 UbiVac Latest Developments

13.17 Momotaro-Gene Inc.

13.17.1 Momotaro-Gene Inc. Company Information

13.17.2 Momotaro-Gene Inc. Prostate Cancer Vaccines Product Offered

13.17.3 Momotaro-Gene Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Momotaro-Gene Inc. Main Business Overview

13.17.5 Momotaro-Gene Inc. Latest Developments

13.18 Vaccibody AS

13.18.1 Vaccibody AS Company Information

13.18.2 Vaccibody AS Prostate Cancer Vaccines Product Offered

13.18.3 Vaccibody AS Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Vaccibody AS Main Business Overview

13.18.5 Vaccibody AS Latest Developments

13.19 AlphaVax Inc.

13.19.1 AlphaVax Inc. Company Information

13.19.2 AlphaVax Inc. Prostate Cancer Vaccines Product Offered

13.19.3 AlphaVax Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 AlphaVax Inc. Main Business Overview

13.19.5 AlphaVax Inc. Latest Developments

14 Research Findings and Conclusion

Table 1. Prostate Cancer Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Prostate Cancer Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tablet

Table 4. Major Players of Injection

Table 5. Global Prostate Cancer Vaccines Sales by Type (2017-2022) & (K Units)

Table 6. Global Prostate Cancer Vaccines Sales Market Share by Type (2017-2022)

Table 7. Global Prostate Cancer Vaccines Revenue by Type (2017-2022) & ($ million)

Table 8. Global Prostate Cancer Vaccines Revenue Market Share by Type (2017-2022)

Table 9. Global Prostate Cancer Vaccines Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Prostate Cancer Vaccines Sales by Application (2017-2022) & (K Units)

Table 11. Global Prostate Cancer Vaccines Sales Market Share by Application (2017-2022)

Table 12. Global Prostate Cancer Vaccines Revenue by Application (2017-2022)

Table 13. Global Prostate Cancer Vaccines Revenue Market Share by Application (2017-2022)

Table 14. Global Prostate Cancer Vaccines Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Prostate Cancer Vaccines Sales by Company (2020-2022) & (K Units)

Table 16. Global Prostate Cancer Vaccines Sales Market Share by Company (2020-2022)

Table 17. Global Prostate Cancer Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Prostate Cancer Vaccines Revenue Market Share by Company (2020-2022)

Table 19. Global Prostate Cancer Vaccines Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Prostate Cancer Vaccines Producing Area Distribution and Sales Area

Table 21. Players Prostate Cancer Vaccines Products Offered

Table 22. Prostate Cancer Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Prostate Cancer Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Prostate Cancer Vaccines Sales Market Share Geographic Region (2017-2022)

Table 27. Global Prostate Cancer Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Prostate Cancer Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Prostate Cancer Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Prostate Cancer Vaccines Sales Market Share by Country/Region (2017-2022)

Table 31. Global Prostate Cancer Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Prostate Cancer Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Prostate Cancer Vaccines Sales by Country (2017-2022) & (K Units)

Table 34. Americas Prostate Cancer Vaccines Sales Market Share by Country (2017-2022)

Table 35. Americas Prostate Cancer Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Prostate Cancer Vaccines Revenue Market Share by Country (2017-2022)

Table 37. Americas Prostate Cancer Vaccines Sales by Type (2017-2022) & (K Units)

Table 38. Americas Prostate Cancer Vaccines Sales Market Share by Type (2017-2022)

Table 39. Americas Prostate Cancer Vaccines Sales by Application (2017-2022) & (K Units)

Table 40. Americas Prostate Cancer Vaccines Sales Market Share by Application (2017-2022)

Table 41. APAC Prostate Cancer Vaccines Sales by Region (2017-2022) & (K Units)

Table 42. APAC Prostate Cancer Vaccines Sales Market Share by Region (2017-2022)

Table 43. APAC Prostate Cancer Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Prostate Cancer Vaccines Revenue Market Share by Region (2017-2022)

Table 45. APAC Prostate Cancer Vaccines Sales by Type (2017-2022) & (K Units)

Table 46. APAC Prostate Cancer Vaccines Sales Market Share by Type (2017-2022)

Table 47. APAC Prostate Cancer Vaccines Sales by Application (2017-2022) & (K Units)

Table 48. APAC Prostate Cancer Vaccines Sales Market Share by Application (2017-2022)

Table 49. Europe Prostate Cancer Vaccines Sales by Country (2017-2022) & (K Units)

Table 50. Europe Prostate Cancer Vaccines Sales Market Share by Country (2017-2022)

Table 51. Europe Prostate Cancer Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Prostate Cancer Vaccines Revenue Market Share by Country (2017-2022)

Table 53. Europe Prostate Cancer Vaccines Sales by Type (2017-2022) & (K Units)

Table 54. Europe Prostate Cancer Vaccines Sales Market Share by Type (2017-2022)

Table 55. Europe Prostate Cancer Vaccines Sales by Application (2017-2022) & (K Units)

Table 56. Europe Prostate Cancer Vaccines Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Prostate Cancer Vaccines Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Prostate Cancer Vaccines Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Prostate Cancer Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Prostate Cancer Vaccines Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Prostate Cancer Vaccines Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Prostate Cancer Vaccines Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Prostate Cancer Vaccines Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Prostate Cancer Vaccines Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Prostate Cancer Vaccines

Table 66. Key Market Challenges & Risks of Prostate Cancer Vaccines

Table 67. Key Industry Trends of Prostate Cancer Vaccines

Table 68. Prostate Cancer Vaccines Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Prostate Cancer Vaccines Distributors List

Table 71. Prostate Cancer Vaccines Customer List

Table 72. Global Prostate Cancer Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Prostate Cancer Vaccines Sales Market Forecast by Region

Table 74. Global Prostate Cancer Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Prostate Cancer Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Prostate Cancer Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Prostate Cancer Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Prostate Cancer Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Prostate Cancer Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Prostate Cancer Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Prostate Cancer Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Prostate Cancer Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Prostate Cancer Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Prostate Cancer Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Prostate Cancer Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Prostate Cancer Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Prostate Cancer Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Prostate Cancer Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Prostate Cancer Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Prostate Cancer Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Prostate Cancer Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 92. Dendreon Corporation Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 93. Dendreon Corporation Prostate Cancer Vaccines Product Offered

Table 94. Dendreon Corporation Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Dendreon Corporation Main Business

Table 96. Dendreon Corporation Latest Developments

Table 97. Bavarian Nordic Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. Bavarian Nordic Prostate Cancer Vaccines Product Offered

Table 99. Bavarian Nordic Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Bavarian Nordic Main Business

Table 101. Bavarian Nordic Latest Developments

Table 102. Advantagene Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Advantagene Prostate Cancer Vaccines Product Offered

Table 104. Advantagene Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Advantagene Main Business

Table 106. Advantagene Latest Developments

Table 107. OncBioMune Pharmaceuticals Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product Offered

Table 109. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. OncBioMune Pharmaceuticals Main Business

Table 111. OncBioMune Pharmaceuticals Latest Developments

Table 112. Advaxis immunotherapies Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. Advaxis immunotherapies Prostate Cancer Vaccines Product Offered

Table 114. Advaxis immunotherapies Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Advaxis immunotherapies Main Business

Table 116. Advaxis immunotherapies Latest Developments

Table 117. SOTIO Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. SOTIO Prostate Cancer Vaccines Product Offered

Table 119. SOTIO Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. SOTIO Main Business

Table 121. SOTIO Latest Developments

Table 122. Cleveland BioLabs Inc. Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. Cleveland BioLabs Inc. Prostate Cancer Vaccines Product Offered

Table 124. Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Cleveland BioLabs Inc. Main Business

Table 126. Cleveland BioLabs Inc. Latest Developments

Table 127. Curevac AG Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. Curevac AG Prostate Cancer Vaccines Product Offered

Table 129. Curevac AG Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Curevac AG Main Business

Table 131. Curevac AG Latest Developments

Table 132. Mediolanum Farmaceutici Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. Mediolanum Farmaceutici Prostate Cancer Vaccines Product Offered

Table 134. Mediolanum Farmaceutici Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Mediolanum Farmaceutici Main Business

Table 136. Mediolanum Farmaceutici Latest Developments

Table 137. Pfizer Inc. Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 138. Pfizer Inc. Prostate Cancer Vaccines Product Offered

Table 139. Pfizer Inc. Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Pfizer Inc. Main Business

Table 141. Pfizer Inc. Latest Developments

Table 142. Vaccitech Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 143. Vaccitech Prostate Cancer Vaccines Product Offered

Table 144. Vaccitech Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Vaccitech Main Business

Table 146. Vaccitech Latest Developments

Table 147. Sensei Biotherapeutics Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 148. Sensei Biotherapeutics Prostate Cancer Vaccines Product Offered

Table 149. Sensei Biotherapeutics Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Sensei Biotherapeutics Main Business

Table 151. Sensei Biotherapeutics Latest Developments

Table 152. Medigene AG Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 153. Medigene AG Prostate Cancer Vaccines Product Offered

Table 154. Medigene AG Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Medigene AG Main Business

Table 156. Medigene AG Latest Developments

Table 157. Ultimovacs Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 158. Ultimovacs Prostate Cancer Vaccines Product Offered

Table 159. Ultimovacs Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Ultimovacs Main Business

Table 161. Ultimovacs Latest Developments

Table 162. Oncovir Inc. Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 163. Oncovir Inc. Prostate Cancer Vaccines Product Offered

Table 164. Oncovir Inc. Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Oncovir Inc. Main Business

Table 166. Oncovir Inc. Latest Developments

Table 167. UbiVac Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 168. UbiVac Prostate Cancer Vaccines Product Offered

Table 169. UbiVac Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 170. UbiVac Main Business

Table 171. UbiVac Latest Developments

Table 172. Momotaro-Gene Inc. Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 173. Momotaro-Gene Inc. Prostate Cancer Vaccines Product Offered

Table 174. Momotaro-Gene Inc. Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 175. Momotaro-Gene Inc. Main Business

Table 176. Momotaro-Gene Inc. Latest Developments

Table 177. Vaccibody AS Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 178. Vaccibody AS Prostate Cancer Vaccines Product Offered

Table 179. Vaccibody AS Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 180. Vaccibody AS Main Business

Table 181. Vaccibody AS Latest Developments

Table 182. AlphaVax Inc. Basic Information, Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 183. AlphaVax Inc. Prostate Cancer Vaccines Product Offered

Table 184. AlphaVax Inc. Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 185. AlphaVax Inc. Main Business

Table 186. AlphaVax Inc. Latest Developments

List of Figures

Figure 1. Picture of Prostate Cancer Vaccines

Figure 2. Prostate Cancer Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prostate Cancer Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Prostate Cancer Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Prostate Cancer Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tablet

Figure 10. Product Picture of Injection

Figure 11. Global Prostate Cancer Vaccines Sales Market Share by Type in 2021

Figure 12. Global Prostate Cancer Vaccines Revenue Market Share by Type (2017-2022)

Figure 13. Prostate Cancer Vaccines Consumed in Hospital

Figure 14. Global Prostate Cancer Vaccines Market: Hospital (2017-2022) & (K Units)

Figure 15. Prostate Cancer Vaccines Consumed in Clinic

Figure 16. Global Prostate Cancer Vaccines Market: Clinic (2017-2022) & (K Units)

Figure 17. Prostate Cancer Vaccines Consumed in Others

Figure 18. Global Prostate Cancer Vaccines Market: Others (2017-2022) & (K Units)

Figure 19. Global Prostate Cancer Vaccines Sales Market Share by Application (2017-2022)

Figure 20. Global Prostate Cancer Vaccines Revenue Market Share by Application in 2021

Figure 21. Prostate Cancer Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Prostate Cancer Vaccines Revenue Market Share by Company in 2021

Figure 23. Global Prostate Cancer Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Prostate Cancer Vaccines Revenue Market Share by Geographic Region in 2021

Figure 25. Global Prostate Cancer Vaccines Sales Market Share by Region (2017-2022)

Figure 26. Global Prostate Cancer Vaccines Revenue Market Share by Country/Region in 2021

Figure 27. Americas Prostate Cancer Vaccines Sales 2017-2022 (K Units)

Figure 28. Americas Prostate Cancer Vaccines Revenue 2017-2022 ($ Millions)

Figure 29. APAC Prostate Cancer Vaccines Sales 2017-2022 (K Units)

Figure 30. APAC Prostate Cancer Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. Europe Prostate Cancer Vaccines Sales 2017-2022 (K Units)

Figure 32. Europe Prostate Cancer Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Prostate Cancer Vaccines Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Prostate Cancer Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. Americas Prostate Cancer Vaccines Sales Market Share by Country in 2021

Figure 36. Americas Prostate Cancer Vaccines Revenue Market Share by Country in 2021

Figure 37. United States Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Prostate Cancer Vaccines Sales Market Share by Region in 2021

Figure 42. APAC Prostate Cancer Vaccines Revenue Market Share by Regions in 2021

Figure 43. China Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Prostate Cancer Vaccines Sales Market Share by Country in 2021

Figure 50. Europe Prostate Cancer Vaccines Revenue Market Share by Country in 2021

Figure 51. Germany Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Prostate Cancer Vaccines Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Prostate Cancer Vaccines Revenue Market Share by Country in 2021

Figure 58. Egypt Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Prostate Cancer Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Prostate Cancer Vaccines in 2021

Figure 64. Manufacturing Process Analysis of Prostate Cancer Vaccines

Figure 65. Industry Chain Structure of Prostate Cancer Vaccines

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles